Access the full text.
Sign up today, get DeepDyve free for 14 days.
Bradley Carra, M. Clemenshaw (2015)
Intracranial Leptomeningeal Carcinomatosis from Breast Cancer Detected on 18F-FDG PETThe Journal of Nuclear Medicine Technology, 43
F. Zagouri, T. Sergentanis, R. Bartsch, A. Berghoff, D. Chrysikos, E. Azambuja, M. Dimopoulos, M. Preusser (2013)
Intrathecal administration of trastuzumab for the treatment of meningeal carcinomatosis in HER2-positive metastatic breast cancer: a systematic review and pooled analysisBreast Cancer Research and Treatment, 139
S. Tolaney, S. Sahebjam, É. Rhun, T. Bachelot, P. Kabos, A. Awada, D. Yardley, A. Chan, P. Conte, V. Diéras, N. Lin, M. Bear, Sonya Chapman, Zhengyu Yang, Yanyun Chen, C. Anders (2020)
A Phase II Study of Abemaciclib in Patients with Brain Metastases Secondary to Hormone Receptor–Positive Breast CancerClinical Cancer Research, 26
G. Frisk, T. Svensson, L. Bäcklund, E. Lidbrink, P. Blomqvist, K. Smedby (2012)
Incidence and time trends of brain metastases admissions among breast cancer patients in SwedenBritish Journal of Cancer, 106
J. Lee, M. Melisko, M. Magbanua, Andrea Kablanian, Janet Scott, H. Rugo, John Park (2015)
Detection of cerebrospinal fluid tumor cells and its clinical relevance in leptomeningeal metastasis of breast cancerBreast Cancer Research and Treatment, 154
SY Chae (2019)
10.1016/S1470-2045(18)30936-7Lancet Oncol., 20
G. Aurilio, D. Disalvatore, G. Pruneri, V. Bagnardi, G. Viale, G. Curigliano, L. Adamoli, E. Munzone, A. Sciandivasci, F. Vita, A. Goldhirsch, F. Nolè (2014)
A meta-analysis of oestrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 discordance between primary breast cancer and metastases.European journal of cancer, 50 2
Bomi Gil, E. Hwang, Song Lee, J. Jang, H. Choi, S. Jung, K. Ahn, B. Kim (2016)
Detection of Leptomeningeal Metastasis by Contrast-Enhanced 3D T1-SPACE: Comparison with 2D FLAIR and Contrast-Enhanced 2D T1-Weighted ImagesPLoS ONE, 11
H. Rudnicka, A. Niwińska, M. Murawska (2007)
Breast cancer leptomeningeal metastasis—the role of multimodality treatmentJournal of Neuro-Oncology, 84
(2016)
Fluoro-17beta-estradiol PET to image the estrogen receptor in vivo: the groningen experience
J. Boers, C. Schröder, G. Hospers, E. Vries, A. Glaudemans (2020)
Detection of Dural Metastases Before the Onset of Clinical Symptoms by 16α-[18F]Fluoro-17β-Estradiol PET in a Patient With Estrogen Receptor-Positive Breast Cancer.Clinical Nuclear Medicine
R. Malani, M. Fleisher, P. Kumthekar, Xuling Lin, A. Omuro, M. Groves, N. Lin, M. Melisko, A. Lassman, S. Jeyapalan, A. Seidman, Anna Skakodub, A. Boire, L. Deangelis, M. Rosenblum, J. Raizer, E. Pentsova (2020)
Cerebrospinal fluid circulating tumor cells as a quantifiable measurement of leptomeningeal metastases in patients with HER2 positive cancerJournal of Neuro-Oncology, 148
Clasina Venema, G. Apollonio, G. Hospers, C. Schröder, R. Dierckx, E. Vries, A. Glaudemans (2016)
Recommendations and Technical Aspects of 16&agr;-[18F]Fluoro-17&bgr;-Estradiol PET to Image the Estrogen Receptor In Vivo: The Groningen ExperienceClinical Nuclear Medicine, 41
J. Watanabe, K. Mitsuya, S. Nakamoto, H. Harada, S. Deguchi, N. Hayashi, Y. Nakasu (2021)
Leptomeningeal Metastasis in ER + HER2- Advanced Breast Cancer Patients: A Review of the Cases in a Single Institute Over a 15-year PeriodBreast Cancer Research and Treatment, 189
E. Kim, Soon‐Tae Lee, Young Kim, J. Byun, Junshik Hong, Dong-Yeop Shin, Y. Koh, Inho Kim (2020)
High Cell-Free DNA Levels in Cerebrospinal Fluid Predict Leptomeningeal Seeding of Hematologic MalignancyJournal of Clinical Neurology (Seoul, Korea), 16
B. Scott, S. Kesari (2013)
Leptomeningeal metastases in breast cancer.American journal of cancer research, 3 2
Accurate determination of the hormone receptor status in patients with breast cancer is necessary to provide better palliative treatment because of the frequent discordant status of hormone receptors between primary breast cancer and metastatic lesions. In particular, the invasive nature and small number of cells recovered from the cerebrospinal fluid collected through lumbar puncture limit the detailed immunocytochemistry investigation of leptomeningeal metastasis. Moreover, none of the conventional imaging modalities provide any information on the hormone receptor status of leptomeningeal metastasis in patients with breast cancer. Herein, we report estrogen receptor–positive leptomeningeal metastasis clearly demonstrated by 16α-[18F]-fluoro-17β-estradiol ([18F]-FES) positron emission tomography/computed tomography (PET/CT) in a patient with metastatic breast cancer.
Nuclear Medicine and Molecular Imaging – Springer Journals
Published: Apr 1, 2022
Keywords: Breast cancer; Leptomeningeal metastasis; 16α-[18F]-fluoro-17β-estradiol ([18F]-FES); Estrogen receptor
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.